Genfleet Therapeutics (Shanghai) Inc.
Recent events
Recent events tied to this brand in public sources.
Back to profile2 entries
2021
GenFleet Therapeutics completes $75 million Series C financing
GenFleet Therapeutics announced completion of a $75 million Series C financing led by Huagai Capital, with new and existing investors participating.
2020
JinFang Medicine completes Series B financing
JinFang Medicine announced that it had completed a Series B financing of nearly RMB 400 million, co-led by CDH Investments and Shenzhen Capital Group's healthcare fund, with other investors participating and existing investors increasing their investment.